Icpt Stock News

3 Red-Hot Stocks that Will Profit from the Death of Comcast Get on board now and see how to play these rising stars for as little as $3 a share. 03 for Intercept Pharmaceuticals Inc; that's greater than it is for 92. Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to. FDA for Obeticholic Acid in Patients with Fibrosis Due to NASH. ICPT stock news. 5 Top Healthcare Stocks for 2019 Free Report Here Forget. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it has submitted a New Drug Application (NDA) to the U. Better Buy: Intercept Pharmaceuticals vs. Free current stock price quotes and data for Intercept Pharmaceuticals Inc (ICPT). (ICPT) stock news and headlines to help you in your trading and investing decisions. Bollinger Bands are 55. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases. Stock Markets close in 3 hours, 17 minutes. View a financial market summary for ICPT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ICPT (Intercept Pharmaceuticals Inc. DOW JONES, A NEWS CORP COMPANY News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. The Fly team scours all sources of company news, from mainstream to cutting edge,then filters out the noise to deliver shortform stories consisting of only market moving content. Let's see how smart they are Last week it went up $5. Albeit the study meets its goals, the stock declines in after-hours trading. Treatment with OCA resulted in early and sustained improvements of commercially available noninvasive biomarker and imaging assessments of fibrosis Additional patient-reported outcomes data demonstrate that pruritus in patients treated with OCA 25 mg did not have an impact on measures of quality of life NEW YORK, Nov. and all the companies you research at NASDAQ. 04 percent on Tuesday, October 29, 2019, on 79 percent of normal volume. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). But along the way some stocks are going to perform badly. 8% in the last two days (as of 12:33 PM; Source: Google finance). ICPT stock news. stock market and it is a holding in 41 U. Find the latest Intercept Pharmaceuticals, Inc. Biotech stocks provide a tremendous opportunity for gains, but it is also a risky. com reports. 369,929 shares of the company were exchanged, compared to its average volume of 769,046. Research news, charts, stock market performance and earnings. (ICPT) shares are suddenly exploding 4. Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals Inc's stock rating is based on fundamental analysis. Join over 50,000 investors who get the latest news from ETFDailyNews. 1,123 people own Intercept Pharmaceuticals on Robinhood on November 1, 2019. ETF market. , a development stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. Find a variety of Intercept Pharma statistics including live ICPT stock quotes, market price charts, market cap, and everything you need to know to invest in ICPT. This website utilizes cookies and similar technologies for functionality and other purposes including personalization of content. 67; that's higher than the P/S ratio of 88. , a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases. 00, for a total value of $44,625. To this end, you can use the Real Investment Advice Platform to avail yourself of various video, audio and proprietary collections of information at your leisure to learn and gather the necessary information that you may need in the fields of investment news, investment opinion, financial news, financial opinion, economic news and economic. Underwriters over-allotment is an additional 351,563 shares. Intercept Pharmaceuticals, Inc. Intercept Pharma (Nasdaq: ICPT) stock rose 280% Thursday thanks to news on a liver drug. Video results for ICPT from Market News Video - ICPT. Customise your news feed and gain expert insights into ICPT on the Nasdaq with Financial Juice for free today!. ICPT - Intercept Pharmaceuticals Inc Stock quote - CNNMoney. ICPT - Stock Chart. Prices of a stock will move throughout the day. Explore commentary on Intercept Pharmaceuticals Inc. ICPT - Intercept Pharmaceuticals Inc Stock quote - CNNMoney. The stock lost its. NEW YORK, October 11, 2017 – Bragar Eagel & Squire, P. Both companies aim. (NASDAQ: ICPT). ICPT Stock Summary. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive. Barron's also provides information on historical stock ratings, target prices, company earnings, market. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to. and the firm feels the stock may continue to trade. View a financial market summary for ICPT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ICPT (Intercept Pharmaceuticals Inc. Intercept Pharmaceuticals Inc. Headlines about ICPT stock have been trending very negative on Sunday, InfoTrie Sentiment Analysis reports. To this end, you can use the Real Investment Advice Platform to avail yourself of various video, audio and proprietary collections of information at your leisure to learn and gather the necessary information that you may need in the fields of investment news, investment opinion, financial news, financial opinion, economic news and economic. Their average twelve-month price target is $130. ICPT investment & stock information. The company has. According to the report, the. Most Popular Articles. While this is more bad news for Gilead, it may prove to be great news for Intercept Pharmaceuticals Inc. and hear what. and all the companies you research at NASDAQ. (NASDAQ:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive. reminds investors that a class action lawsuit has been filed in the U. ICPT NEWS - IBD PARTNERS Gilead Stock Is Among The Biggest Biotech Stocks — But Should You Buy It? Gilead is the second biggest biotech company behind Amgen (AMGN) in terms of market valuation. Wedbush maintained Intercept Pharmaceuticals, Inc. 00 and the low price target for ICPT is $68. 67; that's higher than the P/S ratio of 88. com! Subscribe. 01, as the stock lost 6. Two primary endpoints were set, but only. The shares were sold at an average price of $85. Lou Carlozo | Nov. 3K shares and relative volume is now at 1. To this end, you can use the Real Investment Advice Platform to avail yourself of various video, audio and proprietary collections of information at your leisure to learn and gather the necessary information that you may need in the fields of investment news, investment opinion, financial news, financial opinion, economic news and economic. (NASDAQ: ICPT). Research stocks, ETFs, REITs and more. Compare Brokers The 10 Best Stocks to Buy to Finish Out 2018. 8 billion in market cap, today on good news about a drug trial. Why Intercept Pharmaceuticals, Weight Watchers International, and Canopy Growth Slumped Today Gloomy views of these businesses sent their stocks lower. Securities products and services offered to self-directed investors through ST Invest, LLC. The stock has a market cap of $1. NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. Certain indications on the ICPT stock chart are why I believe that Intercept Pharmaceuticals Inc (NASDAQ:ICPT) stock is on the verge of breaking out toward much higher prices. What's going on at Intercept Pharmaceuticals (NASDAQ:ICPT)? View breaking news headlines for ICPT stock from trusted media outlets at MarketBeat. Intercept Pharmaceuticals (ICPT) stock changed position at -0. Intercept Pharmaceuticals - ICPT - Stock Price & News | The Motley Fool. District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Intercept Pharmaceuticals, Inc. To wit, the Intercept Pharmaceuticals, Inc. The biopharmaceutical company reported ($2. Looking for stock market analysis and research with proves results? Zacks. Latest data: Intercept Pharmaceuticals. Use the Advanced Stock Chart's date range selection to toggle between short term and long term stock price charts for ICPT, from one-day to 3-year. ICPT - Stock Chart. Quote Stock Analysis News Price vs Fair Value Trailing Returns Financials Valuation Operating Performance Dividends Ownership Executive News. Intercept Pharmaceuticals (ICPT) stock price, charts, trades & the US's most popular. Get breaking news and analysis on Intercept Pharmaceuticals, Inc. Shares of Intercept Pharmaceuticals Inc (NASDAQ:ICPT) are taking a beating today on the back of earnings that did not live up to Wall Street expectations. Wedbush maintained Intercept Pharmaceuticals, Inc. 24), Briefing. Stock market analysts and brokers have recently amended their target prices on shares of Intercept Pharmaceuticals, Inc. StockBrain ranks all published news articles on a scale from -1 (red, most negative) to 1 (green, most positive). Intercept Pharmaceuticals, Inc. Biotech stocks provide a tremendous opportunity for gains, but it is also a risky. Anyone wanting to profit from biotech must read this. Latest News about ICPT Data & News supplied by www. On Tuesday, November 05, 2019, Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), the company witnessed their stock drop by $-4. That means we are expecting the stock ICPT to move 6%. Intercept Pharmaceuticals, Inc. 84% to close at $58. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Intercept Pharmaceuticals against related stocks people have also bought like SRPT, EXEL, GILD, and VKTX. (NASDAQ:ICPT). 7 million from the exercise of options to purchase common stock net of payments of. InterCept, Inc. Enanta's Stock Down Despite NASH Drug Meeting Goal in. Wedbush maintained Intercept Pharmaceuticals, Inc. Free current stock price quotes and data for Intercept Pharmaceuticals Inc (ICPT). Intercept Pharmaceuticals, Inc. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful. 46B market cap Intercept Pharmaceuticals Inc (NASDAQ:ICPT) released another year of negative earnings, investors may be on edge waiting for breakeven. and hear what. , a development stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. ETF market. The current EPS for the company has recorded at $-10. Intercept Pharmaceuticals, Inc. Large buy-outs made by the board is what attracts investor attention to this stock. Biotech suffered losses toward the end of 2018 along with the broader stock market but bounced back in early 2019. 69 points higher from last closing price of $65. 91 while a Beta factor of the stock stands at 1. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). To wit, the Intercept Pharmaceuticals, Inc. Securities products and services offered to self-directed investors through ST Invest, LLC. Chart, Quote and financial news from the leading provider and award-winning BigCharts. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it has submitted a New Drug. (NASDAQ:ICPT) is one of the stocks that are taking the center stage today as the company shares are trading 4. The bands have been in this wide range for 5 bars. You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. ICPT - Market Data & News. Technical Analysis of Intercept Pharmaceuticals, Inc. Customise your news feed and gain expert insights into ICPT on the Nasdaq with Financial Juice for free today!. The recent performance of Intercept Pharmaceuticals (NASDAQ:ICPT) stock in the market spoke loud and clear to investors as ICPT saw more than 577. The company announced positive clinical data, exciting investors and. Latest data: Intercept Pharmaceuticals. As a result, Options for ICPT could expire worthless. Intercept Pharmaceuticals Inc's stock rating is based on fundamental analysis. Intercept Pharmaceuticals (ICPT) Stock: Weak On High Volume Today Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news. These institutions hold a total of 26,483,042 shares. I especially like researching new gadgets. Member FINRA / SIPC. (NASDAQ: ICPT) Intercept Pharmaceuticals News & Technicals On Thursday after the close Intercept Pharmaceuticals announced that the U. ICPT - Intercept Pharmaceuticals Inc Stock quote - CNNMoney. FDA for Obeticholic Acid in Patients with Fibrosis Due to NASH. 69 points higher from last closing price of $65. Following the sale. Treatment with OCA resulted in early and sustained improvements of commercially available noninvasive biomarker and imaging assessments of fibrosis Additional patient-reported outcomes data demonstrate that pruritus in patients treated with OCA 25 mg did not have an impact on measures of quality of life NEW YORK, Nov. 19% in the last day ( Thursday, 31st Oct 2019 ) from $74. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. According to the report, the. Prices of a stock will move throughout the day. The Motley Fool. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Home Stock Screener Forex Screener Crypto Screener Economic Calendar Shows How It Works Chart Features Pricing House Rules Moderators Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Help Center Refer a friend Feature Request Blog & News FAQ Wiki Twitter. 01, as the stock lost 6. Let's see how smart they are Last week it went up $5. Better Buy: Intercept Pharmaceuticals vs. is a company in the U. A crucial question to bear in mind when you’re an investor of an unprofitable business, is whether the company will have to raise more capital in the near future. Intercept Pharmaceuticals (NASDAQ:ICPT) issued its quarterly earnings data on Tuesday. Fundamentals by Morningstar. Rumor trading desk in NYC has a very smart buyer in name. View a financial market summary for ICPT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ICPT (Intercept Pharmaceuticals Inc. ICPT: Get the latest Intercept Pharmaceuticals stock price and detailed information including ICPT news, historical charts and realtime prices. com offers in-depth financial research with over 30years of proven results. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT). Find the latest Intercept Pharmaceuticals, Inc. Looking at the ICPT split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Stocks to invest in – Hedge Fund and Insider Trading News: David Rich, Autonomy Capital, Third Point LLC, Intercept Pharmaceuticals Inc (ICPT), Procter & Gamble Co (PG), and More. Biotech suffered losses toward the end of 2018 along with the broader stock market but bounced back in early 2019. NEW YORK, October 11, 2017 – Bragar Eagel & Squire, P. Two primary endpoints were set, but only. Video results for ICPT from Market News Video - ICPT. Barron's also provides information on historical stock ratings, target prices, company earnings, market. TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. peak in the last 4 years. ICPT | Complete Intercept Pharmaceuticals Inc. , a development stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. According to the latest research reports released, 5 analysts have issued a rating of “buy”, 3 analysts “outperform”, 4 analysts “hold”, 4 analysts “underperform” and 0 analysts “sell”. 67K shares in trading volumes in the last trading session, way higher than the average trading volume of 571. Latest News about ICPT Data & News supplied by www. Intercept shares ended their last trading session up 3. While this is more bad news for Gilead, it may prove to be great news for Intercept Pharmaceuticals Inc. (NASDAQ:ICPT). Real time Intercept Pharmaceuticals (ICPT) stock price quote, stock graph, news & analysis. Equity multiplier, or assets relative to shareholders' equity, comes in at 10. Back to ICPT Stock Lookup Intercept Pharma (ICPT) – Rumors May 23, 2019 01:15 PM RBC Capital Continues to View Intercept Pharmaceuticals (ICPT) as a Takeover Target. However, the ICPT surcharge for household users will remain unchanged, TNB said. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its third quarter 2019 financial results prior. Get India stock market quotes, stock quote news india, latest share prices for ICPT. Gilead Sciences | The Motley Fool 11:30am, Saturday, 21'st Sep 2019. 369,929 shares of the company were exchanged, compared to its average volume of 769,046. View Intercept Pharmaceuticals, Inc. 36% on Tuesday. Stocks Rankings for ICPT. View the real-time ICPT price chart on Robinhood and decide if you want to buy or sell commission-free. Ford sold 800 shares of the firm’s stock in a transaction that occurred on Monday, September 16th. Two primary endpoints were set, but only. ICPT got hammered on a "sell the news" set of presentations at a major liver meeting last week. Research news, charts, stock market performance and earnings. Technical Analysis of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) Intercept Pharmaceuticals News & Technicals On Thursday after the close Intercept Pharmaceuticals announced that the U. What's next for the stock? We take a look at earnings estimates for some clues. com! Subscribe. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts. (ICPT) stock quote, history, news and other vital information to help you with your stock trading and investing. Read Zacks Investment Research's latest article on Investing. 04 percent on Tuesday, October 29, 2019, on 79 percent of normal volume. Latest stock price today and the US's most active stock market forums. Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. NEW YORK, May 10, 2019 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals Inc ICPT financial information, fundamentals, key ratios, market capitalization, shares outstanding, float, and short interest. 3 Red-Hot Stocks that Will Profit from the Death of Comcast Get on board now and see how to play these rising stars for as little as $3 a share. Why Intercept Pharmaceuticals, Weight Watchers International, and Canopy Growth Slumped Today Gloomy views of these businesses sent their stocks lower. According to the report, the. Enanta's Stock Down Despite NASH Drug Meeting Goal in. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Intercept Pharmaceuticals (ICPT) stock changed position at -0. ICPT investment & stock information. A crucial question to bear in mind when you’re an investor of an unprofitable business, is whether the company will have to raise more capital in the near future. (ICPT) News – Find the latest company news headlines for Intercept Pharmaceuticals, Inc. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. ICPT's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. ICPT has closed below upper band by 17. advanced stock charts by MarketWatch. Video results for ICPT from Market News Video - ICPT. 01, as the stock lost 6. ICPT: Get the latest Intercept Pharmaceuticals stock price and detailed information including ICPT news, historical charts and realtime prices. Gilead Sciences | The Motley Fool 11:30am, Saturday, 21'st Sep 2019. It focuses on the discovering, developing and commercializing of novel therapeutics to treat chronic liver diseases utilizing its proprietary bile acid chemistry. Zacks 256d. Equity multiplier, or assets relative to shareholders' equity, comes in at 10. The high price target for ICPT is $243. Reuters India provides latest news & articles on stock market quotes, online stock quotes, India. Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Practical application of the products herein are at your own risk and Financhill. Intercept Pharmaceuticals (ICPT) Stock: Weak On High Volume Today Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news. ICPT investment & stock information. The ICPT YTD return is shown above. An increase of 25% from the average daily volume of 745,943 shares. Intercept Pharmaceuticals (ICPT) has 0 splits in our ICPT split history database. Top Stories Best & Worst Articles Video News Featured Articles Best Stocks "A" Rated Stocks Upgrades/Downgrades High Yield Dividend Stocks Stock Screener Industry Rank Best ETFs "A" Rated ETFs Best ETF Categories High Yield ETFs POWR Ratings™ Upgrades/Downgrades Watchlist Screener Services. Intercept Pharmaceuticals, Inc. 88% of US stocks. Looking for stock market analysis and research with proves results? Zacks. On the day. Analyst recommendation for this stock stands at 8. Find recent news headlines for a specific symbol on this page. Join over 50,000 investors who get the latest news from ETFDailyNews. Looking at the ICPT split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. ICPT - Stock Valuation Report. , a development stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. ICPT | Complete Intercept Pharmaceuticals Inc. After analyzing the stock closely, I found that there is no solid support until a double bottom at $92. Looking at the ICPT split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. ICPT - Stock Chart. To wit, the Intercept Pharmaceuticals, Inc. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Intercept Pharmaceuticals Inc. Breaking News: ICPT latest news. is a company in the U. The stock of Intercept Pharmaceuticals, Inc. Find the latest Intercept Pharmaceuticals, Inc. Get the latest Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals (ICPT) Stock: Weak On High Volume Today Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news. Generally speaking long term investing is the way to go. is a biopharmaceutical company. ICPT stock quote, chart and news. ICPT detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. All Aboard the ICPT Rocketship!!!! Majority of analysts are on board that this stock is at least worth 3x what it's trading for now. ICPT traded up $1. 74% to closing price of $65. Intercept Pharmaceuticals (ICPT) stock price, charts, trades & the US's most popular. ICPT After Hours Trading and Pre-Market Trading After-Hours Trades Nasdaq. is a development stage biopharmaceutical company. com is an advanced financial information center and next-generation communication platform that connects self-directed investors with startup and small cap companies, market experts, and. is a single-source provider of a broad range of technologies, products and services that work together to meet the technology and operating needs of financial institutions. NEW YORK , Oct. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). advanced stock charts by MarketWatch. FDA for Obeticholic Acid in Patients with Fibrosis Due to NASH. Generally speaking long term investing is the way to go. 00 on news it is commencing an underwritten public offering of $200m of its common stock and $200m of convertible senior notes. View detailed stock price information for Intercept Pharmaceuticals Inc. and hear what. Large buy-outs made by the board is what attracts investor attention to this stock. com offers in-depth financial research with over 30years of proven results. The bands have been in this wide range for 5 bars. Looking at the ICPT split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. The Motley Fool. Technical Analysis of Intercept Pharmaceuticals, Inc. Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. 7 million from the exercise of options to purchase common stock net of payments of. Enanta's Stock Down Despite NASH Drug Meeting Goal in. (ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it has priced its underwritten public offering of 2,400,000 shares of its common stock at a. (NASDAQ: ICPT) Intercept Pharmaceuticals, Inc. You can contact me and ask me anything about science and technology. 96) Downgrade to hold with an unchanged target price (TP) of RM13. traded on unusually high volume on Jan. ICPT stock is down 50% in the past four months, after the company reported some side effects including itching for Ocaliva when used in the treatment for NASH (nonalcoholic steatohepatitis), despite positive data from phase 3 trials. The Company is focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. Intercept Pharmaceuticals, Inc. Fundamentals by Morningstar. , (NASDAQ: ICPT) recorded at $74. View a financial market summary for ICPT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to ICPT (Intercept Pharmaceuticals Inc. We certainly feel for shareholders who bought near the top. Intercept Submits New Drug Application to the U. Intercept Pharmaceuticals stock quote and ICPT charts. The ICPT YTD return is shown above. NEW YORK , Oct. Top Stories Best & Worst Articles Video News Featured Articles Best Stocks "A" Rated Stocks Upgrades/Downgrades High Yield Dividend Stocks Stock Screener Industry Rank Best ETFs "A" Rated ETFs Best ETF Categories High Yield ETFs POWR Ratings™ Upgrades/Downgrades Watchlist Screener Services. Underwriters over-allotment is an additional 351,563 shares. advanced stock charts by MarketWatch. Intercept Pharmaceuticals (ICPT) stock price, charts, trades & the US's most popular. Find the latest Intercept Pharmaceuticals, Inc. ICPT - Ticker Symbol Lookup, Stock Quotes. The stock was sold at an average price of $70.